2017
DOI: 10.1186/s13018-017-0579-y
|View full text |Cite
|
Sign up to set email alerts
|

Metal-on-metal hip resurfacing in patients younger than 50 years: a retrospective analysis

Abstract: BackgroundThe Nordic registry reports patients under 50 years old with total hip replacements realize only 83% 10-year implant survivorship. These results do not meet the 95% 10-year survivorship guideline posed by the UK’s National Institute for Health and Care Excellence (NICE) in 2014.MethodsThe purpose of this study is threefold: First, we evaluate if metal-on-metal hip resurfacing arthroplasty meets these high standards in younger patients. Next, we compare outcomes between age groups to determine if youn… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
14
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 22 publications
(17 citation statements)
references
References 55 publications
2
14
0
Order By: Relevance
“…In our cohort, only females with normal bone density (as confirmed with a DEXA scan) underwent HRA and we did not notice any statistical difference in outcome between genders. Similarly, Gaillard et al 10 also noted no statistical difference between males and females in their series using the ReCap Magnum uncemented HRA implant. 10 We had only 6 hips with head sizes of 44-46 and none of them have had any symptoms or metal ion levels above MHRA guideline values.…”
Section: Discussionmentioning
confidence: 77%
See 3 more Smart Citations
“…In our cohort, only females with normal bone density (as confirmed with a DEXA scan) underwent HRA and we did not notice any statistical difference in outcome between genders. Similarly, Gaillard et al 10 also noted no statistical difference between males and females in their series using the ReCap Magnum uncemented HRA implant. 10 We had only 6 hips with head sizes of 44-46 and none of them have had any symptoms or metal ion levels above MHRA guideline values.…”
Section: Discussionmentioning
confidence: 77%
“…Similarly, Gaillard et al 10 also noted no statistical difference between males and females in their series using the ReCap Magnum uncemented HRA implant. 10 We had only 6 hips with head sizes of 44-46 and none of them have had any symptoms or metal ion levels above MHRA guideline values. The lack of statistically significant difference based on head sizes may be attributed to their low numbers in our cohort.…”
Section: Discussionmentioning
confidence: 77%
See 2 more Smart Citations
“…Individual series and hip registries are now publishing excellent long-term (15 to 20 years) survivorship results of MoM THA with the Metasul ® bearing and of certain MoM HRA including BHR, CONSERVE PLUS (Microport Orthopaedics, Boston, MA, USA) and RECAP (Biomet Inc., Warsaw, IN, USA) [67][68][69]. A paper reporting short-term results from the Finnish registry put the BHR forward was the best hip replacement option [70].…”
mentioning
confidence: 99%